Impaired maturation and function of dendritic cells by mycobacteria through IL-1β
✍ Scribed by Masahiko Makino; Yumi Maeda; Tetsu Mukai; Stefan H. E. Kaufmann
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 261 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Dendritic cells (DC) are pivotal for initiation and regulation of innate and adaptive immune responses evoked by vaccination and natural infection. After infection, mycobacterial pathogens first encounter monocytes, which produce pro‐inflammatory cytokines, including IL‐1β, TNF‐α and IL‐6. The role of these cytokines in DC maturation remains incompletely understood. Here, we show that maturation of DC from monocytes was impaired by pretreatment of monocytes with low doses of IL‐1β. Under these conditions, Mycobacterium leprae‐infected DC failed to stimulate antigen‐specific T cell responses. Expression of CD86 and CD83 and production of IL‐12 in response to lipopolysaccharide and peptidoglycan were diminished. In contrast, these DC functions were not impaired by pretreatment with TNF‐α, IL‐6 or IL‐10. When monocytes were infected with M. bovis Bacillus Calmette‐Guérin, and subsequently differentiated to DC, the activity of these DC was suppressed as well. Thus, IL‐1β acts at early stages of differentiation of DC and impairs biological functions of DC at later stages. Therefore, production of IL‐1β by mycobacteria‐infected antigen‐presenting cells counteracts effective stimulation of innate and adaptive immune responses.
📜 SIMILAR VOLUMES
## Abstract Chronic inflammation is associated with promotion of malignancy and tumor progression. Many tumors enhance the accumulation of myeloid‐derived suppressor cells (MDSC), which contribute to tumor progression and growth by suppressing anti‐tumor immune responses. Tumor‐derived IL‐1β secret
As CD40 plays a key role in both antitumor immunity and DC maturation, we have studied the regulation of its expression during DC hematopoiesis (dendropoiesis) in vitro and in vivo in the tumor microenvironment. Using MC38 colon adenocarcinoma tumor models, we have demonstrated that DCs generated in